Amedeo's Top 20

Amedeo Smart

Independent Medical Education

02 January 2023

Multidisciplinary Journal Club

  1. Ageno W, Bertu L, Bucherini E, Camporese G, et al.
    Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial.
    BMJ 2022;379:e072623.

  1. Owen DH, Singh N, Ismaila N, Blanchard E, et al.
    Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.2.
    J Clin Oncol 2022.

  2. Yaeger R, Weiss J, Pelster MS, Spira AI, et al.
    Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C.
    N Engl J Med 2022.

  3. Barrio IR, Miki Y, Jaunmuktane ZT, Warner T, et al.
    Association Between Orthostatic Hypotension and Dementia in Patients With Parkinson Disease and Multiple System Atrophy.
    Neurology 2022.

  4. Harrow M, Jobe TH, Tong L.
    Twenty-year effects of antipsychotics in schizophrenia and affective psychotic disorders.
    Psychol Med 2022;52:2681-2691.

  1. Wang A, Meng X, Tian X, Zuo Y, et al.
    Ticagrelor-Aspirin vs Clopidogrel-Aspirin in CYP2C19 Loss-of-Function Carriers With Minor Stroke or TIA Stratified by Risk Profile.
    Neurology 2022.

  2. Kopmar NE, Cassaday R.
    How I Prevent and Treat Central Nervous System Disease in Adults with Acute Lymphoblastic Leukemia.
    Blood 2022.

  3. Hughes LM, Irwin MG, Nestor CC.
    Alternatives to remifentanil for the analgesic component of total intravenous anaesthesia: a narrative review.
    Anaesthesia 2022.

  4. Marti-Fabregas J, Camps-Renom P, Best JG, Ramos-Pachon A, et al.
    Stroke Risk and Antithrombotic Treatment During Follow-up of Patients With Ischemic Stroke and Cortical Superficial Siderosis.
    Neurology 2022.

  5. Thiele J, Kvasnicka HM, Orazi A, Gianelli U, et al.
    The international consensus classification of myeloid neoplasms and acute Leukemias: myeloproliferative neoplasms.
    Am J Hematol 2023;98:166-179.

  1. Douros A, Ante Z, Suissa S, Brassard P, et al.
    Common vaccines and the risk of incident dementia: a population-based cohort study.
    J Infect Dis 2022.

  2. Signori A, Lorscheider J, Vukusic S, Trojano M, et al.
    Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network.
    J Neurol Neurosurg Psychiatry 2023;94:23-30.

  3. Sorstedt E, Tetens MM, Nilsson S, Nowak P, et al.
    Impact of pre-antiretroviral treatment HIV-RNA on time to successful virological suppression and subsequent virological failure - two nationwide, population-based cohort studies.
    AIDS 2023;37:279-286.

  4. Massicotte-Azarniouch D, Detwiler RK, Hu Y, Falk RJ, et al.
    Malignancy risk in kidney transplant recipients exposed to immunosuppression pre-transplant for the treatment of glomerulonephritis.
    Nephrol Dial Transplant 2022.

  5. Yang L, Deng YT, Leng Y, Ou YN, et al.
    Depression, Depression Treatments, and Risk of Incident Dementia: A Prospective Cohort Study of 354,313 Participants.
    Biol Psychiatry 2022.

  1. Yu G, Tong S, Liu J, Wan Y, et al.
    A systematic review of cost‑effectiveness analyses of sequential treatment for osteoporosis.
    Osteoporos Int 2022.

  2. Szaflarski JP, Devinsky O, Lopez M, Park YD, et al.
    Long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies: 4-year results from the expanded access program.
    Epilepsia 2022.

  3. Lengton R, van der Willik EM, de Rooij ENM, Meuleman Y, et al.
    Effect of residual kidney function and dialysis adequacy on chronic pruritus in dialysis patients.
    Nephrol Dial Transplant 2022.

  4. Tao K, Chen H, Chen Y, Gu Y, et al.
    Levetiracetam induces severe psychiatric symptoms in people with epilepsy.
    Seizure 2022.

  5. Magri F, Bellingeri C, De Maggio I, Croce L, et al.
    A first-trimester serum TSH in the 4-10 mIU/L range is associated with obstetric complications in thyroid peroxidase antibody-negative women.
    J Endocrinol Invest 2022.


more..

Privacy Policy